Date post: | 22-Apr-2015 |
Category: |
Health & Medicine |
Upload: | patvocates |
View: | 1,065 times |
Download: | 3 times |
Social Networks for e-Patients Sharing Accurate, Current Information and Data
ACORCommunities
ACORCommunities
ACORCommunities
ACORCommunities
Started 1995, initially as central archival site for cancer listservs
Community center started 19961996
No commerce, no ads, no fluff!
Purely an information provider & community builder
ECCO :: 25/09/11 2
AC
OR
.or
gA
CO
R.o
rg
HISTORYHISTORY
165165 public communities and 5050 private
All communitiesAll communities have closed archives. ACOR is part of the deep webdeep web
Current membership: 60K60K
Served >600K>600K subscribers since 19961996
Delivering on average ~ 1,5 Million~ 1,5 Million emails weekly
ECCO :: 25/09/11 3
AC
OR
.or
gA
CO
R.o
rg
STATSSTATS
STATSSTATS
Community size: from 60 subscribers to 3K.
Optimal size for active groups: 1-3 K. Could be larger
Many cancer are orphan diseases. But disease specific community of 1,000s. Can represent significant % of patient population
ECCO :: 25/09/11 4
AC
OR
.or
gA
CO
R.o
rg
Helping cancer e-patients. Worldwide.
Promoting dissemination of scientific information in a supportive environment
Facilitating personal story sharing, with emphasis on medically or QOL significant events
ECCO :: 25/09/11 5
AC
OR
.or
gA
CO
R.o
rg
GOALS: ACTIVATIONGOALS: ACTIVATION
Access to relevant & current information
Bypassing built-in ‘Lethal Lag Time’
Research opportunities with patient participation
Data collection from within communities
Clinical trial recruitmentECCO :: 25/09/11 6
AC
OR
.or
gA
CO
R.o
rg
GOALS: ACCELERATIONGOALS: ACCELERATION
Knowledge is in constant Beta
No individual can fully keep up with medical currency
ECCO :: 25/09/11 7
AC
OR
.or
gA
CO
R.o
rg
ISSUES: KNOWLEDGEISSUES: KNOWLEDGE
•Much that is problematic of the professional, as the purveyor of expert knowledge, derives from the fact that she/ he is at most only one step ahead of enlightened lay practitioners.
•Anthony GiddensThe Consequences of Modernity, 1999
ECCO :: 25/09/11 8
AC
OR
.or
gA
CO
R.o
rg
ISSUES: KNOWLEDGEISSUES: KNOWLEDGE
It’s not the size of the data that kills you, it’s the size of the metadata.
The methods of social science are dear in time and money and getting dearer every day.
ECCO :: 25/09/11 9
AC
OR
.or
gA
CO
R.o
rg
ISSUES: DATAISSUES: DATA
ECCO :: 25/09/11 10
AC
OR
.or
gA
CO
R.o
rg
ISSUES: LETHAL LAG-TIMEISSUES: LETHAL LAG-TIME
•We just can’t wait any longer
•It takes an average of 17 years to implement clinical research results in daily practice
•Andrew Balas, MD, PhD, 2000
ECCO :: 25/09/11 11
AC
OR
.or
gA
CO
R.o
rg
ISSUES: LETHAL LAG TIMEISSUES: LETHAL LAG TIME
The plural of anecdote is NOT data
Large compendiums of patient conversations are more than anecdotes
More than 3/4 of medical interventions are either self-help or take place without any healthcare professional
Scientists & doctors are patients too
ECCO :: 25/09/11 12
AC
OR
.or
gA
CO
R.o
rg
ISSUES: CONVERSATIONSISSUES: CONVERSATIONS
The patient is the most underutilized resource of the healthcare system.
Let Patients Help!
Making the user the point of integration has the potential to be profoundly different & more efficient than current practices
ECCO :: 25/09/11 13
AC
OR
.or
gA
CO
R.o
rg
SOLUTIONSSOLUTIONS
SOCIODEMOGRAPHICSSOCIODEMOGRAPHICS
14
Health Status
ECCO :: 25/09/11
Other Status
AC
OR
.or
gA
CO
R.o
rg
SOCIODEMOGRAPHICSSOCIODEMOGRAPHICS
15ECCO :: 25/09/11
AC
OR
.or
gA
CO
R.o
rg
With Gleevec & GIST, ACOR saved many lives & record-breaking trial accrual
Myeloma group conducted ground-breaking post-marketing study on biphosphanates and necrosis of the jaw
For renal cell carcinoma, patients from 1 major institution: they learn they would never be told of the only potentially curative treatment
Across system, daily conversations about side effects that are not found in FDA public documentation
ECCO :: 25/09/11 16
AC
OR
.or
gA
CO
R.o
rg
RESULTSRESULTS
Zometa approved in Feb. 2002, as successor to Aredia
Approval of 15 minute infusion without any mention of kidney toxicity or high creatinine level
IMF/ACOR’s MYELOMA start to receive reports of high creatinine levels, some with serious renal failure
After getting advice from experts messages to MYELOMA telling everyone that infusion time MUST be 30 minute
Kidney issues from Zometa dramatically reducedECCO :: 25/09/11 17
AC
OR
.or
gA
CO
R.o
rg
ADVERSE EVENT REPORTADVERSE EVENT REPORT
Osteo Necrosis of the Jaw (ONJ) reported in 2 studies of Zometa (2003,2004)
MYELOMA group started telling members talking any biphosphanates they should avoid any invasive procedure to the jaw - tooth extraction a common trigger
IMF used MYLEOMA group to conduct survey. 904 members responded in 30 days, captured data for diagnosis, treatments & complications
Results published at ASH, FDA ODAC & NEJM (Durie, Katz, Crowley; 07/07/05, p99)
ECCO :: 25/09/11 18
AC
OR
.or
gA
CO
R.o
rg
ADVERSE EVENT REPORTADVERSE EVENT REPORT
Social networks of rare cancer patients are often the best source of high quality information. Rethink what are authoritative answersauthoritative answers
Networked patients are inventing and shaping a better healthcare model
LET PATIENTS HELP!
We have seen nothing yet!ECCO :: 25/09/11 19
CONCLUSIONSCONCLUSIONSA
CO
R.o
rg
AC
OR
.or
g
•Doctors will get off their pedestals when patients get off their knees
•- Dr. Tom Ferguson
20ECCO :: 25/09/11
AC
OR
.org
AC
OR
.org